Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-23-005526
Filing Date
2023-04-05
Accepted
2023-04-05 21:28:06
Documents
2
Period of Report
2023-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7594
2 robertkimmdpoa.htm EX-24 8535
  Complete submission text file 0001567619-23-005526.txt   17724
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kim Robert Young (Reporting) CIK: 0001971608 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 23804228